Literature DB >> 16188976

Reconstitution and molecular analysis of an active human immunodeficiency virus type 1 Nef/p21-activated kinase 2 complex.

Alexa Raney1, Lillian S Kuo, Laura L Baugh, John L Foster, J Victor Garcia.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) Nef activation of p21-activated kinase 2 (PAK-2) was recapitulated in a cell-free system consisting of in vitro-transcribed RNA, rabbit reticulocyte lysate, and microsomal membranes on the basis of the following observations: (i) Nef associated with a kinase endogenous to the rabbit reticulocyte lysate that was identified as PAK-2, (ii) Nef-associated kinase activity was detected with Nefs from HIV-1(SF2), HIV-1(YU2), and SIV(mac239), (iii) kinase activation was not detected with a myristoylation-defective Nef (HIV-1(SF2)NefG2A) or with a Nef defective in PAK-2 activation but fully competent in other Nef functions (HIV-1(SF2)NefF195I), and (iv) Nef-associated kinase activation required activated endogenous p21 GTPases (Rac1 or Cdc42). The cell-free system was used to analyze the mechanism of Nef activation of PAK-2. First, studies suggest that the p21 GTPases may act transiently to enhance Nef activation of PAK-2 in vitro. Second, addition of wortmannin to the cell-free system demonstrated that Nef activation of PAK-2 does not require PI 3-kinase activity. Third, ultracentrifugation analysis revealed that whereas the majority of Nef and PAK-2 partitioned to the supernatant, Nef-associated PAK-2 activity partitioned to the membrane-containing pellet as a low-abundance complex. Lastly, Nef activation of PAK-2 in vitro requires addition of microsomal membranes either during or after translation of the Nef RNA. These results are consistent with a model in which activation of PAK-2 by Nef occurs by recruiting PAK-2 to membranes. As demonstrated herein, the cell-free system is a new and important tool in the investigation of the mechanism of PAK-2 activation by Nef.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16188976      PMCID: PMC1235864          DOI: 10.1128/JVI.79.20.12732-12741.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

Review 1.  HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication.

Authors:  Alison L Greenway; Gavan Holloway; Dale A McPhee; Phoebe Ellis; Alyssa Cornall; Michael Lidman
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

2.  Rac1 and Rac3 are targets for geranylgeranyltransferase I inhibitor-mediated inhibition of signaling, transformation, and membrane ruffling.

Authors:  Patricia L Joyce; Adrienne D Cox
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

Review 3.  In vivo analysis of Nef function.

Authors:  Bangdong L Wei; Vivek K Arora; John L Foster; Donald L Sodora; J Victor Garcia
Journal:  Curr HIV Res       Date:  2003-01       Impact factor: 1.581

Review 4.  The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3.

Authors:  Lawrence P Kane; Arthur Weiss
Journal:  Immunol Rev       Date:  2003-04       Impact factor: 12.988

5.  Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort.

Authors:  J C Learmont; A F Geczy; J Mills; L J Ashton; C H Raynes-Greenow; R J Garsia; W B Dyer; L McIntyre; R B Oelrichs; D I Rhodes; N J Deacon; J S Sullivan
Journal:  N Engl J Med       Date:  1999-06-03       Impact factor: 91.245

6.  Cyclic Nucleotide-independent protein kinases from rabbit reticulocytes. Identification and characterization of a protein kinase activated by proteolysis.

Authors:  S M Tahara; J A Traugh
Journal:  J Biol Chem       Date:  1981-11-25       Impact factor: 5.157

7.  Nef proteins from simian immunodeficiency virus-infected chimpanzees interact with p21-activated kinase 2 and modulate cell surface expression of various human receptors.

Authors:  Frank Kirchhoff; Michael Schindler; Nicola Bailer; G Herma Renkema; Kalle Saksela; Volker Knoop; Michaela C Müller-Trutwin; Mario L Santiago; Frederic Bibollet-Ruche; Matthias T Dittmar; Jonathan L Heeney; Beatrice H Hahn; Jan Münch
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 8.  Phosphoinositide 3-kinase-dependent activation of Rac.

Authors:  Heidi C E Welch; W John Coadwell; Len R Stephens; Phillip T Hawkins
Journal:  FEBS Lett       Date:  2003-07-03       Impact factor: 4.124

Review 9.  Phosphoinositide 3-kinase: diverse roles in immune cell activation.

Authors:  Jonathan A Deane; David A Fruman
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

10.  HIV-1 Nef binds the DOCK2-ELMO1 complex to activate rac and inhibit lymphocyte chemotaxis.

Authors:  Ajit Janardhan; Tomek Swigut; Brian Hill; Michael P Myers; Jacek Skowronski
Journal:  PLoS Biol       Date:  2004-01-20       Impact factor: 8.029

View more
  9 in total

1.  Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.

Authors:  Marta J Gonzalez-Hernandez; Michael D Swanson; Rafael Contreras-Galindo; Sarah Cookinham; Steven R King; Richard J Noel; Mark H Kaplan; David M Markovitz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  Activation of p21-activated kinase 2 by human immunodeficiency virus type 1 Nef induces merlin phosphorylation.

Authors:  Bangdong L Wei; Vivek K Arora; Alexa Raney; Lillian S Kuo; Guang-Hui Xiao; Eduardo O'Neill; Joseph R Testa; John L Foster; J Victor Garcia
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Human immunodeficiency virus type 1 Nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activity.

Authors:  Susanne Rauch; Kati Pulkkinen; Kalle Saksela; Oliver T Fackler
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

4.  A Conserved Acidic-Cluster Motif in SERINC5 Confers Partial Resistance to Antagonism by HIV-1 Nef.

Authors:  Charlotte A Stoneham; Peter W Ramirez; Rajendra Singh; Marissa Suarez; Andrew Debray; Christopher Lim; Xiaofei Jia; Yong Xiong; John Guatelli
Journal:  J Virol       Date:  2020-03-17       Impact factor: 5.103

5.  Trans-cellular introduction of HIV-1 protein Nef induces pathogenic response in Caenorhabditis elegans.

Authors:  Aamir Nazir; Shreesh Raj Sammi; Pankaj Singh; Raj Kamal Tripathi
Journal:  PLoS One       Date:  2010-12-13       Impact factor: 3.240

6.  Nef-mediated enhancement of cellular activation and human immunodeficiency virus type 1 replication in primary T cells is dependent on association with p21-activated kinase 2.

Authors:  Kevin C Olivieri; Joya Mukerji; Dana Gabuzda
Journal:  Retrovirology       Date:  2011-08-05       Impact factor: 4.602

Review 7.  HIV-1 Nef: at the crossroads.

Authors:  John L Foster; J Victor Garcia
Journal:  Retrovirology       Date:  2008-09-22       Impact factor: 4.602

8.  Lovastatin Inhibits HIV-1-Induced MHC-I Downregulation by Targeting Nef-AP-1 Complex Formation: A New Strategy to Boost Immune Eradication of HIV-1 Infected Cells.

Authors:  Bingfeng Liu; Xu Zhang; Wanying Zhang; Liyang Wu; Shuliang Jing; Weiwei Liu; Baijin Xia; Fan Zou; Lijuan Lu; Xiancai Ma; Dalian He; Qifei Hu; Yiwen Zhang; Kai Deng; Weiping Cai; Xiaoping Tang; Tao Peng; Hui Zhang; Linghua Li
Journal:  Front Immunol       Date:  2019-09-10       Impact factor: 7.561

9.  Caveolin-1 reduces HIV-1 infectivity by restoration of HIV Nef mediated impairment of cholesterol efflux by apoA-I.

Authors:  Shanshan Lin; Peter E Nadeau; Xiaomei Wang; Ayalew Mergia
Journal:  Retrovirology       Date:  2012-10-15       Impact factor: 4.602

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.